HBsAg LOSS IS HIGHER AMONG CAUCASIANS COMPARED TO ASIANS AFTER STOPPING NUCLEOS(T)IDE ANALOGUE THERAPY: RESULTS FROM A LARGE, GLOBAL, MULTI-ETHNIC COHORT OF PATIENTS WITH CHRONIC HEPATITIS B (RETRACT-B STUDY)

被引:0
|
作者
Hirode, Grishma [1 ,2 ]
Choi, Hannah S. J. [1 ]
Su, Tung-Hung [3 ]
Wong, Grace Lai-Hung [4 ]
Seto, Wai-Kay [5 ]
Van Hees, Stijn [6 ]
Papatheodorie, Margarita [7 ]
Brakenhoff, Sylvia [8 ]
Lens, Sabela [9 ,10 ]
Sarowat, Arif [1 ]
Chien, Rong-Nan [11 ]
Forns, Xavier [9 ,10 ]
Sonneveld, Milan J. [8 ]
Papatheodoridie, George [7 ]
Vanwolleghem, Thomas [6 ]
Yuen, Man-Fung [12 ]
Chan, Henry Lik Yuen [4 ]
Kao, Jia-Horng [3 ]
Hsu, Yao-Chun
Chen, Chien-Hung [13 ,14 ]
Hansen, Bettina E. [1 ,2 ]
Cornberg, Markus [15 ]
Jeng, Wen-Juei [11 ]
Janssen, Harty L. A. [16 ]
机构
[1] Univ Hlth Network, Toronto Gen Hosp, Toronto Ctr Liver Dis, Toronto, ON, Canada
[2] Toronto Viral Hepatitis Care Network VIRCAN, Toronto, ON, Canada
[3] Natl Taiwan Univ Hosp, Taipei, Taiwan
[4] Chinese Univ Hong Kong, Hong Kong, Peoples R China
[5] Univ Hong Kong, Hong Kong, Peoples R China
[6] Antwerp Univ Hosp, Dept Gastroenterol & Hepatol, Antwerp, Belgium
[7] Natl & Kapodistrian Univ Athens, Sch Med, Gen Hosp Athens Laiko, Dept Gastroenterol, Athens, Greece
[8] Erasmus MC, Univ Med Ctr, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands
[9] Hosp Clin Barcelona, Idibaps, Barcelona, Spain
[10] Ciberehd, Barcelona, Spain
[11] Chang Gung Mem Hosp, Taoyuan, Taiwan
[12] Univ Hong Kong, Med, Hong Kong, Peoples R China
[13] E DA Hosp, Fu Jen Catholic Univ Hosp, Kaohsiung, Taiwan
[14] Kaohsiung Chang Gung Mem Hosp, Kaohsiung, Taiwan
[15] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany
[16] Univ Hlth Network, Toronto Ctr Liver Dis, Viral Hepatitis Care Network VIRCAN, Toronto, ON, Canada
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
23
引用
收藏
页码:19A / 20A
页数:2
相关论文
共 50 条
  • [31] Nucleos(t)ide analogue therapy decreases the HBeAg loss rate in HBeAg positive chronic hepatitis B patients with hepatitis flare: a propensity score matching study
    Peng, Chien-Wei
    Jeng, Rachel Wen-Juei
    Chen, Yi-Cheng
    Chien, Rong-Nan
    Liaw, Yun-Fan
    JOURNAL OF HEPATOLOGY, 2020, 73 : S862 - S863
  • [32] Limited sustained response after stopping nucleos(t)ide analogues in patients with chronic hepatitis B: results from a randomised controlled trial (Toronto STOP study)
    Liem, Kin Seng
    Fung, Scott
    Wong, David K.
    Yim, Colina
    Noureldin, Seham
    Chen, Jiayun
    Feld, Jordan J.
    Hansen, Bettina E.
    Janssen, Harry L. A.
    GUT, 2019, 68 (12) : 2206 - 2213
  • [33] BEPIROVIRSEN (BPV) IN PATIENTS WITH CHRONIC HEPATITIS B VIRUS (HBV) INFECTION CONTROLLED BY NUCLEOS(T)IDE ANALOGUE THERAPY: HBV DNA AND HBsAg LOSS 6 MONTHS AFTER END OF BPV TREATMENT (B-CLEAR STUDY)
    Yuen, Man-Fung
    Lim, Seng Gee
    Plesniak, Robert
    Tsuji, Keiji
    Diaconescu, Gheorghe
    Gadano, Adrian C.
    Asselah, Tarik
    Yim, Hyung-Joon
    Heo, Jeong
    Rizzardini, Giuliano
    Janssen, Harry L.
    Popescu, Corneliu Petru
    Stefanova-Petrova, Diana
    Wong, Alexander
    Idriz, Nevin
    Pojoga, Cristina
    Tanaka, Yasuhito
    Janczewska, Ewa
    Cremer, Jennifer
    Elston, Robert
    Lukic, Tamara
    Maynard, Lauren
    Kendrick, Stuart
    Bharania, Punam
    Campbell, Fiona
    Paff, Melanie
    Theodore, Dickens
    HEPATOLOGY, 2023, 77 (05) : E129 - E130
  • [34] HBEAG LOSS INCIDENCE RATE DECLINED SHARPLY AFTER FIRST YEAR IN HBEAG POSITIVE CHRONIC HEPATITIS B PATIENTS RECEIVING NUCLEOS(T)IDE ANALOGUE THERAPY
    Peng, Chien-Wei
    Jeng, Wen-Juei
    Chien, Rong-Nan
    Liaw, Yun-Fan
    HEPATOLOGY, 2019, 70 : 315A - 315A
  • [35] Long Term HBsAg Responses to Peg-Interferon Alpha-2b in HBeAg Negative Chronic Hepatitis B Patients Developing Clinical Relapse after Stopping Long-Term Nucleos(t)ide Analogue Therapy
    Kumar, Karan
    Jindal, Ankur
    Gupta, Ekta
    Trehanpati, Nirupma
    Shasthry, Saggere M.
    Maiwall, Rakhi
    Arora, Vinod
    Bhardwaj, Ankit
    Kumar, Guresh
    Kumar, Manoj
    Sarin, Shiv K.
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2024, 14 (01)
  • [36] HBsAg loss rates remain low during 3-year follow-up of HBeAg negative patients with chronic hepatitis B after nucleos(t)ide analogue withdrawal: results of the Toronto STOP Study
    Liem, Kin Seng
    Moazen, Bahareh
    Fung, Scott K.
    Wong, David K. H.
    Chen, Jiayun
    Yim, Colina K.
    Noureldin, Seham
    Feld, Jordan J.
    Hansen, Bettina E.
    Janssen, Harry L. A.
    HEPATOLOGY, 2019, 70 : 288A - 289A
  • [37] Switching to tenofovir alafenamide for nucleos(t)ide analogue-experienced patients with chronic hepatitis B: Week 144 results from a real-world, multicentre cohort study
    Ogawa, Eiichi
    Nakamuta, Makoto
    Koyanagi, Toshimasa
    Ooho, Aritsune
    Furusyo, Norihiro
    Kajiwara, Eiji
    Dohmen, Kazufumi
    Kawano, Akira
    Satoh, Takeaki
    Takahashi, Kazuhiro
    Azuma, Koichi
    Yamashita, Nobuyuki
    Yamashita, Naoki
    Sugimoto, Rie
    Amagase, Hiromasa
    Kuniyoshi, Masami
    Ichiki, Yasunori
    Morita, Chie
    Kato, Masaki
    Shimoda, Shinji
    Nomura, Hideyuki
    Hayashi, Jun
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 56 (04) : 713 - 722
  • [38] Efficacy and safety of bepirovirsen in patients with chronic hepatitis B virus infection on stable nucleos (t)ide analogue therapy: interim results from the randomised phase 2b B-Clear study
    Yuen, Man-Fung
    Plesniak, Robert
    Lim, Seng Gee
    Tsuji, Keiji
    Diaconescu, Gheorghe
    Gadano, Adrian
    Kim, Ju Hyun
    Asselah, Tarik
    Yim, Hyung Joon
    Heo, Jeong
    Rizzardini, Giuliano
    Janssen, Harry
    Popescu, Corneliu Petru
    Petrova, Diana
    Wong, Alexander
    Indriz, Nevin
    Pojoga, Cristina
    Tanaka, Yasuhito
    Gusev, Denis
    Janczewska, Ewa
    Cremer, Jennifer
    Elston, Robert
    Lukic, Tamara
    Maynard, Lauren
    Kendrick, Stuart
    Bharania, Punam
    Campbell, Fiona
    Paff, Melanie
    Theodore, Dickens
    JOURNAL OF HEPATOLOGY, 2022, 77 : S13 - S13
  • [39] Efficacy and safety of bepirovirsen in patients with chronic hepatitis B virus infection not on stable nucleos (t)ide analogue therapy: interim results from the randomised phase 2b B-Clear study
    Lim, Seng Gee
    Pojoga, Cristina
    Janssen, Harry
    Gusev, Denis
    Plesniak, Robert
    Tsuji, Keiji
    Janczewska, Ewa
    Popescu, Corneliu Petru
    Andreone, Pietro
    Hou, Jinlin
    Arbune, Manuela
    Gadano, Adrian
    Petrova, Diana
    Inoue, Jun
    Piratvisuth, Teerha
    Lim, Young-Suk
    Leerapun, Apinya
    Atsukawa, Masanori
    Jia, Ji-Dong
    Labio, Eternity
    Cremer, Jennifer
    Elston, Robert
    Lukic, Tamara
    Quinn, Geoff
    Kendrick, Stuart
    Bharania, Punam
    Campbell, Fiona
    Paff, Melanie
    Theodore, Dickens
    JOURNAL OF HEPATOLOGY, 2022, 77 : S880 - S881
  • [40] Off-Treatment Hepatitis B Virus (HBV) DNA Levels and the Prediction of Relapse After Discontinuation of Nucleos(t)ide Analogue Therapy in Patients With Chronic Hepatitis B: A Prospective Stop Study
    Cao, Jiawei
    Chi, Heng
    Yu, Tao
    Li, Zhandong
    Hansen, Bettina E.
    Zhang, Xiaoyong
    Zhong, Chunxiu
    Sun, Jian
    Hou, Jinlin
    Janssen, Harry L. A.
    Peng, Jie
    JOURNAL OF INFECTIOUS DISEASES, 2017, 215 (04): : 581 - 589